144 related articles for article (PubMed ID: 27957801)
21. Analysis of clinicopathological and cytogenetic differences between B-lymphoblastic lymphoma and B-lymphoblastic leukemia in childhood.
Knez V; Bao L; Carstens B; Liang X
Leuk Lymphoma; 2020 Sep; 61(9):2129-2135. PubMed ID: 32427530
[TBL] [Abstract][Full Text] [Related]
22. Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study.
Baughn LB; Biegel JA; South ST; Smolarek TA; Volkert S; Carroll AJ; Heerema NA; Rabin KR; Zweidler-McKay PA; Loh M; Hirsch B
Cancer Genet; 2015; 208(1-2):1-18. PubMed ID: 25678190
[TBL] [Abstract][Full Text] [Related]
23. Microarray testing as an efficient tool to redefine hyperdiploid paediatric B-cell precursor acute lymphoblastic leukaemia patients.
Lejman M; Zawitkowska J; Styka B; Babicz M; Winnicka D; Zaucha-Prażmo A; Pastorczak A; Taha J; Młynarski W; Kowalczyk JR
Leuk Res; 2019 Aug; 83():106163. PubMed ID: 31202078
[TBL] [Abstract][Full Text] [Related]
24. Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression.
Schiffman JD; Lorimer PD; Rodic V; Jahromi MS; Downie JM; Bayerl MG; Sanmann JN; Althof PA; Sanger WG; Barnette P; Perkins SL; Miles RR
Br J Haematol; 2011 Nov; 155(4):477-86. PubMed ID: 21981616
[TBL] [Abstract][Full Text] [Related]
25. The kinetics of blast clearance are associated with copy number alterations in childhood B-cell acute lymphoblastic leukemia.
Urbańska Z; Lejman M; Taha J; Madzio J; Ostrowska K; Miarka-Walczyk K; Wypyszczak K; Styka B; Jakubowska J; Sędek Ł; Szczepański T; Stańczak M; Fendler W; Młynarski W; Pastorczak A
Neoplasia; 2023 Jan; 35():100840. PubMed ID: 36288679
[TBL] [Abstract][Full Text] [Related]
26. Clinical impacts of copy number variations in B-cell differentiation and cell cycle control genes in pediatric B-cell acute lymphoblastic leukemia: a single centre experience.
Crepinsek K; Marinsek G; Kavcic M; Prelog T; Kitanovski L; Jazbec J; Debeljak M
Radiol Oncol; 2021 Dec; 56(1):92-101. PubMed ID: 34957727
[TBL] [Abstract][Full Text] [Related]
27. [Significance of IKZF1 gene copy number abnormalities in BCR/ABL-negative B-lineage acute lymphoblastic leukemia in children].
Zou Y; Liu XM; Zhang L; Chen YM; Guo Y; Chen XJ; Yang WY; Wang SC; Ruan M; Liu TF; Zhang JY; Liu F; Qi BQ; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1154-9. PubMed ID: 26575870
[TBL] [Abstract][Full Text] [Related]
28. IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.
Kuiper RP; Waanders E; van der Velden VH; van Reijmersdal SV; Venkatachalam R; Scheijen B; Sonneveld E; van Dongen JJ; Veerman AJ; van Leeuwen FN; van Kessel AG; Hoogerbrugge PM
Leukemia; 2010 Jul; 24(7):1258-64. PubMed ID: 20445578
[TBL] [Abstract][Full Text] [Related]
29. Prognostic gene alterations and clonal changes in childhood B-ALL.
Erbilgin Y; Firtina S; Mercan S; Hatirnaz Ng O; Karaman S; Tasar O; Karakas Z; Celkan TT; Zengin E; Sarper N; Yildirmak ZY; Sisko S; Ozbek U; Sayitoglu M
Leuk Res; 2019 Aug; 83():106159. PubMed ID: 31228652
[TBL] [Abstract][Full Text] [Related]
30. Digital Multiplex Ligation-Dependent Probe Amplification for Detection of Key Copy Number Alterations in T- and B-Cell Lymphoblastic Leukemia.
Benard-Slagter A; Zondervan I; de Groot K; Ghazavi F; Sarhadi V; Van Vlierberghe P; De Moerloose B; Schwab C; Vettenranta K; Harrison CJ; Knuutila S; Schouten J; Lammens T; Savola S
J Mol Diagn; 2017 Sep; 19(5):659-672. PubMed ID: 28736295
[TBL] [Abstract][Full Text] [Related]
31. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
32. Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms.
Ribera J; Zamora L; Morgades M; Mallo M; Solanes N; Batlle M; Vives S; Granada I; Juncà J; Malinverni R; Genescà E; Guàrdia R; Mercadal S; Escoda L; Martinez-Lopez J; Tormo M; Esteve J; Pratcorona M; Martinez-Losada C; Solé F; Feliu E; Ribera JM;
Genes Chromosomes Cancer; 2017 Nov; 56(11):810-820. PubMed ID: 28758283
[TBL] [Abstract][Full Text] [Related]
33. B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology.
Soslow RA; Baergen RN; Warnke RA
Cancer; 1999 Jun; 85(12):2648-54. PubMed ID: 10375114
[TBL] [Abstract][Full Text] [Related]
34. Complex MLL rearrangement in non-infiltrated bone marrow in an infant with stage II precursor B-lymphoblastic lymphoma.
Ahlmann M; Meyer C; Marschalek R; Burkhardt B; Koehler G; Klapper W; Juergens H; Rossig C
Eur J Haematol; 2014 Oct; 93(4):349-53. PubMed ID: 24635731
[TBL] [Abstract][Full Text] [Related]
35. Fluorescence in situ hybridisation analysis of formalin-fixed paraffin-embedded tissue sections in the diagnostic work-up of non-Burkitt high grade B-cell non-Hodgkin's lymphoma: a single centre's experience.
Foot NJ; Dunn RG; Geoghegan H; Wilkins BS; Neat MJ
J Clin Pathol; 2011 Sep; 64(9):802-8. PubMed ID: 21593346
[TBL] [Abstract][Full Text] [Related]
36. T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses.
Basso K; Mussolin L; Lettieri A; Brahmachary M; Lim WK; Califano A; Basso G; Biondi A; Cazzaniga G; Rosolen A
Genes Chromosomes Cancer; 2011 Dec; 50(12):1063-75. PubMed ID: 21987448
[TBL] [Abstract][Full Text] [Related]
37. Absence of somatic hypermutation of immunoglobulin heavy chain variable region genes in precursor B-lymphoblastic lymphoma: a study of four cases in childhood and adolescence.
Hojo H; Sasaki Y; Nakamura N; Abe M
Am J Clin Pathol; 2001 Nov; 116(5):673-82. PubMed ID: 11710683
[TBL] [Abstract][Full Text] [Related]
38. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Novel Targets, Including CC-Chemokine Receptor 4, in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Mayo Clinic Clinical and Pathologic Study.
Khurana S; Heckman MG; Craig FE; Cochuyt JJ; Greipp P; Rahman ZA; Sproat LZ; Litzow M; Foran JM; Jiang LJ
Arch Pathol Lab Med; 2024 Apr; 148(4):471-475. PubMed ID: 37522711
[TBL] [Abstract][Full Text] [Related]
40. Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma.
Salmerón-Villalobos J; Ramis-Zaldivar JE; Balagué O; Verdú-Amorós J; Celis V; Sábado C; Garrido M; Mato S; Uriz J; Ortega MJ; Gutierrez-Camino A; Sinnett D; Illarregi U; Carron M; Regueiro A; Galera A; Gonzalez-Farré B; Campo E; Garcia N; Colomer D; Astigarraga I; Andrés M; Llavador M; Martin-Guerrero I; Salaverria I
Pediatr Blood Cancer; 2022 Nov; 69(11):e29926. PubMed ID: 36000950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
